UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

European Society of Cardiology smartphone and tablet applications for patients with atrial fibrillation and their health care providers

Europace (London, England), 2018-02, Vol.20 (2), p.225-233

2018

Volltextzugriff (PDF)

Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models

Europace (London, England), 2020-05, Vol.22 (5), p.748-760

2020

Volltextzugriff (PDF)

Clearing the cognitive cloud: direct oral anticoagulants or vitamin K antagonists for reducing dementia risk in patients with atrial fibrillation?

Heart (British Cardiac Society), 2021-12, Vol.107 (23), p.1854-1855

Chua, Winnie

2021

Volltextzugriff (PDF)

The efficacy of a task model approach to ADL rehabilitation in stroke apraxia and action disorganisation syndrome: A randomised controlled trial

PloS one, 2022-03, Vol.17 (3), p.e0264678

2022

Volltextzugriff (PDF)

Disturbed atrial metabolism, shear stress, and cardiac load contribute to atrial fibrillation after ablation: AXAFA biomolecule study

Europace (London, England), 2024-02, Vol.26 (2)

2024

Volltextzugriff (PDF)

Pilot study to evaluate the use of remote patient monitoring to guide the timing of valve intervention in patients with severe asymptomatic aortic stenosis (APRAISE-AS): study protocol for a randomised controlled trial delivered in two tertiary cardiac centres in the UK

BMJ open, 2024-06, Vol.14 (6), p.e086587

2024

Volltextzugriff (PDF)

Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study

PLoS medicine, 2021-02, Vol.18 (2), p.e1003405-e1003405

2021

Volltextzugriff (PDF)

Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5

Europace (London, England), 2020-07, Vol.22 (7), p.1026-1035

2020

Volltextzugriff (PDF)

An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditions

Scientific reports, 2023-10, Vol.13 (1), p.16743-16743, Article 16743

2023

Volltextzugriff (PDF)

Predictors of recurrence of atrial fibrillation within the first 3 months after ablation

Europace (London, England), 2020-09, Vol.22 (9), p.1337-1344

2020

Volltextzugriff (PDF)

Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death

Journal of the American Heart Association, 2022-02, Vol.11 (4), p.e022833-e022833

2022

Volltextzugriff (PDF)

Heart Failure, Female Sex, and Atrial Fibrillation Are the Main Drivers of Human Atrial Cardiomyopathy: Results From the CATCH ME Consortium

Journal of the American Heart Association, 2023-11, Vol.12 (22), p.e031220

2023

Volltextzugriff (PDF)

Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation

JCI insight, 2020-08, Vol.5 (16)

2020

Volltextzugriff (PDF)

Heart failure in patients with atrial fibrillation: why it matters now more than ever

Heart (British Cardiac Society), 2021-08, Vol.107 (16), p.1278-1279

2021

Volltextzugriff (PDF)

Clinical Potential of Targeting Fibroblast Growth Factor-23 and αKlotho in the Treatment of Uremic Cardiomyopathy

Journal of the American Heart Association, 2020-04, Vol.9 (7), p.e016041-e016041

2020

Volltextzugriff (PDF)

Prognostic models for predicting incident or recurrent atrial fibrillation: protocol for a systematic review

Systematic reviews, 2019-08, Vol.8 (1), p.221-221, Article 221

2019

Volltextzugriff (PDF)

Detection of unknown atrial fibrillation by prolonged ECG monitoring in an all-comer patient cohort and association with clinical and Holter variables

Open heart, 2020-05, Vol.7 (1), p.e001151

2020

Volltextzugriff (PDF)

Development and external validation of predictive models for prevalent and recurrent atrial fibrillation: a protocol for the analysis of the CATCH ME combined dataset

BMC cardiovascular disorders, 2019-05, Vol.19 (1), p.120-9, Article 120

2019

Volltextzugriff (PDF)

Biomarkers Associated With Aortic Valve Calcification: Should We Focus on Sex Specific Processes?

Frontiers in cell and developmental biology, 2020-07, Vol.8, p.604-604

2020

Volltextzugriff (PDF)

Mobile Apps to Improve Medication Adherence in Cardiovascular Disease: Systematic Review and Meta-analysis

Journal of medical Internet research, 2021-05, Vol.23 (5), p.e24190-e24190

2021

Volltextzugriff (PDF)

Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation

European heart journal, 2019-04, Vol.40 (16), p.1268-1276

2019

Volltextzugriff (PDF)

Misperceptions among patients with chronic hepatitis B in Singapore

World journal of gastroenterology : WJG, 2005-08, Vol.11 (32), p.5002

2005

Volltextzugriff (PDF)

Fibroblast growth factor 23 shortens left ventricular action potential duration and increases arrhythmogenicity

Journal of molecular and cellular cardiology, 2022-12, Vol.173, p.80-81

2022

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(113)

Publikationsform

Sprache

Englisch
(128)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

European Society of Cardiology smartphone and tablet applications for patients with atrial fibrillation and their health care providers

Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models

Clearing the cognitive cloud: direct oral anticoagulants or vitamin K antagonists for reducing dementia risk in patients with atrial fibrillation?

Expert consensus document: Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment

The efficacy of a task model approach to ADL rehabilitation in stroke apraxia and action disorganisation syndrome: A randomised controlled trial

Disturbed atrial metabolism, shear stress, and cardiac load contribute to atrial fibrillation after ablation: AXAFA biomolecule study

Pilot study to evaluate the use of remote patient monitoring to guide the timing of valve intervention in patients with severe asymptomatic aortic stenosis (APRAISE-AS): study protocol for a randomised controlled trial delivered in two tertiary cardiac centres in the UK

Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study

Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5

An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditions

Predictors of recurrence of atrial fibrillation within the first 3 months after ablation

Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death

Heart Failure, Female Sex, and Atrial Fibrillation Are the Main Drivers of Human Atrial Cardiomyopathy: Results From the CATCH ME Consortium

Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation

Heart failure in patients with atrial fibrillation: why it matters now more than ever

Clinical Potential of Targeting Fibroblast Growth Factor-23 and αKlotho in the Treatment of Uremic Cardiomyopathy

Prognostic models for predicting incident or recurrent atrial fibrillation: protocol for a systematic review

Detection of unknown atrial fibrillation by prolonged ECG monitoring in an all-comer patient cohort and association with clinical and Holter variables

Development and external validation of predictive models for prevalent and recurrent atrial fibrillation: a protocol for the analysis of the CATCH ME combined dataset

Biomarkers Associated With Aortic Valve Calcification: Should We Focus on Sex Specific Processes?

Mobile Apps to Improve Medication Adherence in Cardiovascular Disease: Systematic Review and Meta-analysis

Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation

Misperceptions among patients with chronic hepatitis B in Singapore

Fibroblast growth factor 23 shortens left ventricular action potential duration and increases arrhythmogenicity

Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment

Suchergebnisse filtern